Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Pulmonology

Beyond COPD: Conditions That Mimic Your Symptoms

At a Glance

Shortness of breath and cough do not always mean COPD. Asthma, heart failure, bronchiectasis, and a blood clot in the lung can feel similar, so doctors combine symptom patterns with breathing tests, scans, and blood tests to identify the cause.

Because the main symptoms of COPD—shortness of breath and a persistent cough—are common to many other conditions, getting the “label” right is the most important part of your care. Being treated for COPD when you actually have heart failure or asthma can mean you’re taking medications that won’t work while your true condition goes unmanaged [1][2].

COPD vs. Asthma

Asthma is the most common condition confused with COPD. While they both involve narrowed airways, they typically behave differently. Asthma symptoms tend to be “variable”—triggered by allergies or exercise—and often start in childhood [3]. COPD symptoms are usually “persistent,” starting gradually later in life [4].

  • The Reversibility Challenge: During spirometry, your doctor gives you a “bronchodilator” (rescue inhaler). While a large response (reversibility) is classically associated with asthma, it cannot reliably distinguish the two on its own. Asthma can develop fixed obstruction over time, and COPD can show substantial reversibility [5][2].
  • Coexistence: Many people have features of both. If coexisting asthma is present, your treatment plan will often prioritize inhaled corticosteroids (ICS) to control airway inflammation, and LABA monotherapy should be avoided [6][3][7].

Heart Failure

Heart failure occurs when the heart isn’t pumping blood efficiently, causing fluid to “back up” into the lungs. This leads to breathlessness that feels almost identical to a COPD flare-up [8].

To tell them apart, doctors use clinical clues—like swelling in the ankles (edema) or difficulty breathing when lying flat (orthopnea)—alongside diagnostic testing [9]:

  • NT-proBNP: This blood test measures a protein released when the heart is under stress. While a value below 300 pg/mL is an excellent rule-out threshold for acute dyspnea in the emergency department, chronic outpatient thresholds differ significantly based on age, kidney function, and other factors [8][10]. It must be interpreted alongside your clinical history, ECG, and imaging.

Bronchiectasis

Bronchiectasis is a condition where the airways become permanently widened and scarred, often due to chronic infections [11]. It shares the “clogged pipe” symptoms of chronic bronchitis.

  • The Mucus Difference: While people with COPD often cough up mucus, those with bronchiectasis frequently cough up much larger volumes [11].
  • Imaging: A High-Resolution CT (HRCT) scan definitively visualizes the airway scarring of bronchiectasis [11][12]. Identifying it is vital because it often requires specialized airway clearance techniques [12].

Pulmonary Embolism

A Pulmonary Embolism (PE) is a blood clot in the lung. It is a dangerous condition that can happen alongside COPD or be mistaken for a flare-up [13].

  • Onset: While COPD flare-ups may develop over several days, a PE often hits suddenly, with severe breathlessness and chest pain [14].
  • Testing Pathway: Emergency evaluation of a PE is a clinician-led pathway. Doctors assess your clinical pretest probability first. They may use a D-dimer blood test if your risk is low, but high-risk patients may proceed directly to a CT Pulmonary Angiography (CTPA) scan without waiting for blood markers [15][16].

The Role of DLCO

Your doctor may also order a DLCO test (Diffusion Capacity for Carbon Monoxide). This measures how well your lungs transfer gas into your blood [17].

  • A Low DLCO in a smoker supports the presence of emphysema, where the air sacs are destroyed. However, it can also reflect pulmonary vascular disease, interstitial lung disease, or anemia [18].
  • A Normal DLCO in someone with breathing issues might occur in asthma or chronic bronchitis, but it does not definitively establish an asthma diagnosis [17][19]. Test interpretation requires incorporating hemoglobin correction and a full clinical picture.

Common questions in this guide

How can I tell whether my symptoms are from asthma or COPD?
Asthma symptoms often vary with triggers such as allergies, exercise, cold air, or pets and may begin early in life. COPD symptoms more often persist and develop gradually later in life, but the two conditions can overlap, so symptom history and testing are both needed.
Does a bronchodilator response on spirometry prove that I have asthma?
No. Asthma can cause long-term airway narrowing, and COPD can also show a substantial response to a bronchodilator, so this result alone cannot reliably distinguish the conditions.
Could heart failure be causing my shortness of breath instead of COPD?
Yes, heart failure can cause fluid to build up in the lungs and produce breathlessness that resembles a COPD flare. Ankle swelling, trouble breathing when lying flat, an electrocardiogram, imaging, and an NT-proBNP blood test may help clinicians assess the cause.
How is bronchiectasis different from COPD?
Bronchiectasis causes the airways to become permanently widened and scarred, often after chronic infections, and people may cough up much more mucus. A high-resolution CT scan can show these airway changes, and treatment may include specialized airway-clearance techniques.
When could sudden breathing trouble be a pulmonary embolism?
A pulmonary embolism is a blood clot in the lung and may cause sudden severe breathlessness and chest pain, unlike the slower development often seen with a COPD flare. Clinicians assess the likelihood first and may use a D-dimer blood test for lower-risk patients or CT pulmonary angiography for people at higher risk. Sudden severe symptoms require urgent medical evaluation.
What does a DLCO result tell me about my breathing problems?
DLCO measures how well the lungs transfer gas into the blood. A low result can support emphysema but can also occur with pulmonary vascular disease, interstitial lung disease, or anemia, while a normal result may occur in asthma or chronic bronchitis; the result must be interpreted with other tests.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my spirometry show substantial bronchodilator reversibility, and does that suggest we need to treat coexisting asthma?
  2. 2.What is my DLCO (diffusion capacity) score, and how does it help you interpret my breathlessness alongside other tests?
  3. 3.Given my symptoms, should we order an NT-proBNP blood test to check if heart failure is contributing to my shortness of breath?
  4. 4.Does my CT scan show signs of bronchiectasis, and do I need specialized airway clearance techniques for the mucus?
  5. 5.If my breathing gets worse very suddenly, what is the evaluation pathway to quickly assess for a pulmonary embolism?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    The effect of a post-bronchodilator FEV1/FVC < 0.7 on COPD diagnosis and treatment: a regression discontinuity design.

    Moffett AT, Halpern SD, Weissman GE

    Respiratory research 2025; (26(1)):122 doi:10.1186/s12931-025-03198-6.

    PMID: 40170167
  2. 2

    Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap.

    Annangi S, Coz-Yataco AO

    Respiratory care 2022; (67(4)):440-447 doi:10.4187/respcare.09215.

    PMID: 35338095
  3. 3

    GOLD 2021 Strategy Report: Implications for Asthma-COPD Overlap.

    Roman-Rodriguez M, Kaplan A

    International journal of chronic obstructive pulmonary disease 2021; (16()):1709-1715 doi:10.2147/COPD.S300902.

    PMID: 34163155
  4. 4

    Redefining the overlap of asthma and COPD.

    Drug and therapeutics bulletin 2017; (55(7)):66-69 doi:10.1136/dtb.2017.7.0505.

    PMID: 28701317
  5. 5

    Bronchodilator reversibility in asthma and COPD: findings from three large population studies.

    Janson C, Malinovschi A, Amaral AFS, et al.

    The European respiratory journal 2019; (54(3)) doi:10.1183/13993003.00561-2019.

    PMID: 31221806
  6. 6

    American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.

    Woodruff PG, van den Berge M, Boucher RC, et al.

    American journal of respiratory and critical care medicine 2017; (196(3)):375-381 doi:10.1164/rccm.201705-0973WS.

    PMID: 28636425
  7. 7

    Management of asthma COPD overlap.

    Maselli DJ, Hanania NA

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(4)):335-344 doi:10.1016/j.anai.2019.07.021.

    PMID: 31376487
  8. 8

    N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.

    Januzzi JL, Chen-Tournoux AA, Christenson RH, et al.

    Journal of the American College of Cardiology 2018; (71(11)):1191-1200 doi:10.1016/j.jacc.2018.01.021.

    PMID: 29544601
  9. 9

    Age-adjusted natriuretic peptide thresholds for a diagnosis of heart failure in the community: Diagnostic accuracy study.

    Taylor CJ, Taylor KS, Jones NR, et al.

    ESC heart failure 2025; (12(5)):3552-3568 doi:10.1002/ehf2.15383.

    PMID: 40717271
  10. 10

    [The relevance of biomarkers in acute heart failure].

    Hellenkamp K, von Haehling S

    Der Internist 2019; (60(6)):587-596 doi:10.1007/s00108-019-0606-7.

    PMID: 31089771
  11. 11

    Isolated Elevation in Lung Residual Volume Is Associated With Airway Diseases.

    Kanj AN, Samhouri BF, Poliszuk D, et al.

    Respiratory care 2022; (67(7)):842-849 doi:10.4187/respcare.09687.

    PMID: 35610031
  12. 12

    Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.

    Lindenmaier TJ, Kirby M, Paulin G, et al.

    COPD 2016; (13(2)):224-34 doi:10.3109/15412555.2015.1074666.

    PMID: 26606693
  13. 13

    Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis.

    Aleva FE, Voets LWLM, Simons SO, et al.

    Chest 2017; (151(3)):544-554 doi:10.1016/j.chest.2016.07.034.

    PMID: 27522956
  14. 14

    Diagnosis of pulmonary embolism in patients with acute exacerbations of chronic obstructive pulmonary disease: A cross-sectional study.

    Maritano Furcada J, Castro HM, De Vito EL, et al.

    The clinical respiratory journal 2020; (14(12)):1176-1181 doi:10.1111/crj.13257.

    PMID: 32780471
  15. 15

    Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism.

    Patel P, Patel P, Bhatt M, et al.

    Blood advances 2020; (4(18)):4296-4311 doi:10.1182/bloodadvances.2019001052.

    PMID: 32915980
  16. 16

    Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.

    Raja AS, Greenberg JO, Qaseem A, et al.

    Annals of internal medicine 2015; (163(9)):701-11 doi:10.7326/M14-1772.

    PMID: 26414967
  17. 17

    Office-based DLCO tests help pulmonologists to make important clinical decisions.

    Enright Md P

    Respiratory investigation 2016; (54(5)):305-11.

    PMID: 27566377
  18. 18

    Predictors of Progression in Pre-COPD: The 3P Study Rationale and Design.

    González-Villaescusa C, Tarrasó Castillo J, Martínez-Pitarch D, et al.

    Open respiratory archives 2026; (8(1)):100519 doi:10.1016/j.opresp.2025.100519.

    PMID: 41438363
  19. 19

    Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.

    Harvey BG, Strulovici-Barel Y, Kaner RJ, et al.

    The European respiratory journal 2015; (46(6)):1589-1597 doi:10.1183/13993003.02377-2014.

    PMID: 26541521

This page is for informational purposes only and does not constitute medical advice. A clinician should evaluate new or worsening breathlessness, especially sudden breathlessness or chest pain, to distinguish COPD from other conditions.

Get notified when new evidence is published on chronic obstructive pulmonary disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.